The company's technology targets chemotherapy much more specifically to cancer cells, and thereby spares healthy cells. This results
in increased effectiveness and decreased side effects with the drugs. The target for our drugs is a specific receptor that is 43-times
more numerous on cancer cells than healthy cells (Figure 1).
|
